{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:16:02Z","timestamp":1790619362777,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bone.2020.115539","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T13:50:42Z","timestamp":1595857842000},"page":"115539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis"],"prefix":"10.1016","volume":"140","author":[{"given":"Frederick S.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Al Mukaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Will","family":"Towler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115539_bb0005","series-title":"Heritable Disorders of Connective Tissue","article-title":"Chapter 12. Other heritable and generalized disorders of connective tissue","author":"McKusick","year":"1972"},{"key":"10.1016\/j.bone.2020.115539_bb0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bone.2020.115539_bb0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bone.2020.115539_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/BLO.0b013e318126c049","article-title":"Functional modeling of the ACVR1 (R206H) mutation in FOP","volume":"462","author":"Groppe","year":"2007","journal-title":"Clin. Orthop. Rel. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0025","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1074\/jbc.M801681200","article-title":"Constitutively activated ALK2 and increased SMAD 1\/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva","volume":"284","author":"Fukuda","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bone.2020.115539_bb0030","first-page":"3462","article-title":"The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization","volume":"119","author":"Shen","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115539_bb0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cytogfr.2009.10.006","article-title":"The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling","volume":"20","author":"Kaplan","year":"2009","journal-title":"Cytok. Growth Factor Rev."},{"key":"10.1016\/j.bone.2020.115539_bb0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrrheum.2010.122","article-title":"Inherited human diseases of heterotopic bone formation","volume":"6","author":"Shore","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2020.115539_bb0045","doi-asserted-by":"crossref","first-page":"22542","DOI":"10.1074\/jbc.M109.094557","article-title":"Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva","volume":"285","author":"Song","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115539_bb0050","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.091110","article-title":"ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation","volume":"25","author":"van Dinther","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0055","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva","volume":"287","author":"Chaikaud","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2\u20134","key":"10.1016\/j.bone.2020.115539_bb0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000324230","article-title":"In vitro analysis of dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP","volume":"194","author":"Groppe","year":"2011","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.bone.2020.115539_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","author":"Hino","year":"2015","journal-title":"PNAS"},{"issue":"303","key":"10.1016\/j.bone.2020.115539_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2020.115539_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bone.2017.11.014","article-title":"Activin A amplifies dysregulated BMP signaling and induced chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Wang","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115539_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bone.2017.10.027","article-title":"Variable signaling activity by FOP ACVR1 mutations","volume":"109","author":"Haupt","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115539_bb0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jbmr.3304","article-title":"Depletion of Mast cells and macrophages impairs heterotopic ossification in an ACVR1 (R206H) mouse model of fibrodysplasia ossificans progressiva","volume":"33","author":"Convente","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0090","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/jbmr.1637","article-title":"An Acvr1 Knock-in mouse has fibrodysplasia ossificans progressiva","volume":"27","author":"Chakkalakal","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1242\/dmm.010280","article-title":"Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis","volume":"5","author":"Kaplan","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bone.2020.115539_bb0100","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/stem.1633","article-title":"Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification","volume":"32","author":"Culbert","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.bone.2020.115539_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0046-8177(97)90133-7","article-title":"Bone morphogenetic protein 2\/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva","volume":"28","author":"Gannon","year":"1997","journal-title":"Human Pathol."},{"key":"10.1016\/j.bone.2020.115539_bb0110","doi-asserted-by":"crossref","first-page":"115116","DOI":"10.1016\/j.bone.2019.115116","article-title":"Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva","volume":"130","author":"Towler","year":"2020","journal-title":"Bone"},{"issue":"S-2","key":"10.1016\/j.bone.2020.115539_bb0115","first-page":"437","article-title":"Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. In emerging concepts in pediatric bone disease","volume":"10","author":"Pignolo","year":"2013","journal-title":"Pediat. Endocrinol. Rev."},{"key":"10.1016\/j.bone.2020.115539_bb0120","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1 (R206H) fibrodysplasia ossificans progressiva (FOP) mutation","volume":"31","author":"Chakkalakal","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2106\/JBJS.I.00705","article-title":"Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2020.115539_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/21678707.2020.1751122","article-title":"Druggable targets, clinical trial design and proposed pharmacological management in fibrodysplasia ossificans progressiva","author":"Pignolo","year":"2020","journal-title":"Exp. Opin. Orphan Drugs"},{"issue":"9","key":"10.1016\/j.bone.2020.115539_bb0135","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1359\/jbmr.2003.18.9.1593","article-title":"ALK2 functions as a BMP type I receptor and induces Indian Hedgehog in Chondrocytes during skeletal development","volume":"18","author":"Zhang","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jbmr.2385","article-title":"The type I BMP receptor ACVR1\/ALK2 is required for chondrogenesis during development","volume":"30","author":"Rigueur","year":"2015","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2106\/JBJS.G.00774","article-title":"Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva","volume":"90","author":"Deirmengian","year":"2008","journal-title":"J. Bone Joint Surg. Am."},{"issue":"10","key":"10.1016\/j.bone.2020.115539_bb0150","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00296-015-3301-6","article-title":"Osteochondromas in fibrodysplasia ossificans progressiva: a widespread trait with a streaking but overlooked appearance when arising at femoral bone end","volume":"35","author":"Morales-Piga","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bone.2020.115539_bb0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/21678707.2018.1483232","article-title":"Hereditary multiple exostoses: are there plausible treatment strategies?","volume":"6","author":"Pacifici","year":"2018","journal-title":"Exp. Opin. Orphan Drugs"},{"key":"10.1016\/j.bone.2020.115539_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ydbio.2013.02.008","article-title":"Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in hereditary multiple exostoses","volume":"377","author":"Huegel","year":"2013","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bone.2020.115539_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2106\/00004623-199302000-00009","article-title":"The histopathology of fibrodysplasia ossificans progressiva: an endochondral process","volume":"75-A","author":"Kaplan","year":"1993","journal-title":"J. Bone Joint Surg."},{"key":"10.1016\/j.bone.2020.115539_bb0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13023-019-1068-7","article-title":"Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes","volume":"14","author":"Pignolo","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.bone.2020.115539_bb0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bone.2017.06.009","article-title":"Joint -specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Pignolo","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115539_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcdb.2015.12.013","article-title":"Granting immunity to FOP and catching heterotopic ossification in the act","volume":"49","author":"Kaplan","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bone.2020.115539_bb0185","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bone.2017.12.024","article-title":"ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells","volume":"109","author":"Wang","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115539_bb0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0070-2153(10)90008-2","article-title":"Vertebrate skeletogenesis","volume":"90","author":"Lefebvre","year":"2010","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bone.2020.115539_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1083\/jcb.200112029","article-title":"Requirement for RAR-mediated gene repression in skeletal progenitor differentiation","volume":"158","author":"Weston","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2020.115539_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.200211117","article-title":"Active repression by unligated retinoid receptors in development: less is sometimes more","volume":"161","author":"Weston","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2020.115539_bb0210","doi-asserted-by":"crossref","first-page":"e40814","DOI":"10.7554\/eLife.40814","volume":"7","author":"Lees-Shepard","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.bone.2020.115539_bb0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1091\/mbc.E18-05-0311","article-title":"ACVR1R206H FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification","volume":"30","author":"Haupt","year":"2019","journal-title":"Mol. Biol. Cell"},{"issue":"10","key":"10.1016\/j.bone.2020.115539_bb0220","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/jbmr.3760","article-title":"Elevated BMP and mechanical signaling through YAP1\/RhoA poises FOP mesenchymal progenitors for osteogenesis","volume":"34","author":"Stanley","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115539_bb0225","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bone.2012.12.008","article-title":"Glast-expressing progenitor cells contribute to heterotopic ossification","volume":"53","author":"Kan","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115539_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bone.2018.01.029","article-title":"Stem cells and heterotopic ossification: lessons from animal models","volume":"109","author":"Lees-Shepard","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115539_bb0235","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jbmr.1562","article-title":"Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification","volume":"27","author":"Wosczyna","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2020.115539_bb0240","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41467-018-02872-2","article-title":"Activin-dependent signaling in fibro\/adipogenic progenitors causes fibrodysplasia ossificans progressiva","volume":"9","author":"Lees-Shepard","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2020.115539_bb0245","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s00415-012-6563-x","article-title":"CNS demyelination in fibrodysplasia ossificans progressiva","volume":"259","author":"Kan","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.bone.2020.115539_bb0250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/21678707.2017.1304211","article-title":"Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)","volume":"5","author":"Kaplan","year":"2017","journal-title":"Exp. Opin. Orphan Drugs"},{"key":"10.1016\/j.bone.2020.115539_bb0255","first-page":"1","article-title":"The medical management of fibrodysplasia ossificans progressiva: current treatment considerations","volume":"1","author":"Kaplan","year":"2019","journal-title":"Proc. Intl. Clin. Council FOP"},{"key":"10.1016\/j.bone.2020.115539_bb0260","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/437491a","article-title":"A new grammar for drug discovery","volume":"437","author":"Fishman","year":"2005","journal-title":"Nature"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220303197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:48:31Z","timestamp":1757612911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220303197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":52,"alternative-id":["S8756328220303197"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115539","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115539"}}